News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

9,882 stories indexed, page 165 of 165

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Featured signal

Télécharger le texte de cette page au format PDF

Publisher

French National Agency for Medicines and Health Products Safety (ANSM)

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

French National Agency for Medicines and Health Products Safety (ANSM)Original publisher link

Canonical metadata stays public, while full text remains on the original site.

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Gestion des cookies

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Documents administratifs mis à la disposition du public

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Autorisation de mise sur le marché pour les médicaments

French National Agency for Medicines and Health Products Safety (ANSM)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Un premier produit conforme aux exigences de sécurité du PSP v.2018

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Traitement hormonal de la ménopause : près de 500 000 femmes traitées en 2025, une hausse des utilisations depuis 2022

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Tensions d’approvisionnement sur l’Ambrisentan Viatris : des importations en cours

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Synapse Labs : nous nous prononçons sur les autorisations de mise sur le marché de certains médicaments

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Retour d’information sur le PRAC de juin 2026 (8 – 11 juin)

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Point de situation sur les approvisionnements des produits de contraste

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Neuroleptiques et constipation : vigilance indispensable pour limiter le risque de complications

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Médicaments non utilisés : l’ANSM et l’Assurance Maladie publient les résultats de l’étude Perimed et identifient des leviers pour agir contre le gaspillage

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

L'EMA recommande le retrait de l'autorisation de mise sur le marché de Tavneos

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

L’ANSM classe 7 dérivés synthétiques de la tryptamine sur la liste des stupéfiants

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

L'ANSM alerte après des erreurs médicamenteuses récentes : Testostérone Besins et Androtardyl (et générique) ne sont pas substituables

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Fortes tensions d’approvisionnement sur les comprimés gastro-résistants à base d’acide acétylsalicylique (aspirine) 75 mg et 100 mg

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Finastéride 1 mg : une attestation d’information partagée bientôt nécessaire pour toute dispensation

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Don de sang : contre-indication de 24 mois après une PrEP injectable

ANSM (France)Original source

🇫🇷Jan 1, 1970Regulatoryansm.sante.fr

Actualités

ANSM (France)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Understanding treatment impact and addressing disparities in rare disease care | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Tina’s Big Trip | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Pioneering new possibilities for the rare disease community

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Paving Regulatory Pathways in Rare Disease

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Patient Centric Clinical Trial | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Genomic Innovation to Support Newborn Screening of Rare Diseases | Alexion Global

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Getting to know Nick France, an Alexion R&D Leading Voice | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Getting to know Chathuri Daluwatte, an Alexion R&D Leading Voice | Alexion Global Site

Alexion (AstraZeneca)Original source

🇺🇸Jan 1, 1970Industryalexion.com

Addressing the Unmet Needs of the Amyloidosis Community | Alexion Global Site

Alexion (AstraZeneca)Original source

🇨🇭Jan 1, 1970Researchnews.uzh.ch

Ronny Peterhans to Become New CIO of UZH

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.ch

Between the Olympics and the Lecture Hall

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.ch

A Global Spotlight on LGBTIQ+ Health

University of Zurich - Med NewsOriginal source

🇨🇭Jan 1, 1970Researchnews.uzh.ch

The Puzzle of Fitness Landscapes

University of Zurich - Med NewsOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

World No Tobacco Day 2026: “Unmask the appeal – countering tobacco and nicotine addiction”

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

WHO supports countries to strengthen emergency medical teams amid rising health emergencies across the Eastern Mediterranean Region

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

WHO and the Royal Scientific Society of Jordan collaborate to strengthen laboratory biosafety and biosecurity in the Eastern Mediterranean Region

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

WHO and FAO drive regional collaboration to advance food safety competencies in the African, Near East and Eastern Mediterranean regions

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

The Eastern Mediterranean Region strengthens food safety capacities

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

Statement For Regional Director, WHO Eastern Mediterranean Region: Poliomyelitis

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

Statement by Dr Hanan Balkhy, WHO Regional Director for Blood Donor Day

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

Opening Remarks by Dr Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean Together for a Healthier Future in Egypt: Strengthening partnerships for health

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

Opening Remarks by Dr Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean. at the WHO & GLIDE MOU Signing Ceremony

WHO EMROOriginal source

🌍Jan 1, 1970Regulatoryemro.who.int

GLIDE and WHO partner to accelerate disease elimination across the Eastern Mediterranean Region

WHO EMROOriginal source